BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11807001)

  • 21. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells.
    Qin JZ; Zhang CL; Kamarashev J; Dummer R; Burg G; Döbbeling U
    Blood; 2001 Nov; 98(9):2778-83. PubMed ID: 11675351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.
    Syed V; Ulinski G; Mok SC; Ho SM
    J Natl Cancer Inst; 2002 Apr; 94(8):617-29. PubMed ID: 11959895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
    Willerslev-Olsen A; Krejsgaard T; Lindahl LM; Litvinov IV; Fredholm S; Petersen DL; Nastasi C; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Kilian M; Koralov SB; Odum N
    Blood; 2016 Mar; 127(10):1287-96. PubMed ID: 26738536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
    Marzec M; Halasa K; Kasprzycka M; Wysocka M; Liu X; Tobias JW; Baldwin D; Zhang Q; Odum N; Rook AH; Wasik MA
    Cancer Res; 2008 Feb; 68(4):1083-91. PubMed ID: 18281483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile.
    Harwix S; Zachmann K; Neumann C
    Arch Dermatol Res; 2000 Jan; 292(1):1-8. PubMed ID: 10664008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin-2- or interleukin-4-stimulated T lymphocytes.
    Brunn GJ; Falls EL; Nilson AE; Abraham RT
    J Biol Chem; 1995 May; 270(19):11628-35. PubMed ID: 7744803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells.
    Qin JZ; Kamarashev J; Zhang CL; Dummer R; Burg G; Döbbeling U
    J Invest Dermatol; 2001 Sep; 117(3):583-9. PubMed ID: 11564163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.
    Geskin LJ; Viragova S; Stolz DB; Fuschiotti P
    Blood; 2015 Apr; 125(18):2798-805. PubMed ID: 25628470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive and interleukin-7/interleukin-15 stimulated DNA binding of Myc, Jun, and novel Myc-like proteins in cutaneous T-cell lymphoma cells.
    Qin JZ; Dummer R; Burg G; Döbbeling U
    Blood; 1999 Jan; 93(1):260-7. PubMed ID: 9864169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.
    Abraham RM; Zhang Q; Odum N; Wasik MA
    Cancer Biol Ther; 2011 Dec; 12(12):1019-22. PubMed ID: 22236880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.
    Marzec M; Liu X; Kasprzycka M; Witkiewicz A; Raghunath PN; El-Salem M; Robertson E; Odum N; Wasik MA
    Blood; 2008 Feb; 111(4):2181-9. PubMed ID: 18025151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
    García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Rich B; Dowgiert R; Hirahara K; Hurwitz D; Shibata M; Mirchandani N; Jones DA; Goddard DS; Eapen S; Mizutani H; Kupper TS
    Blood; 2006 Mar; 107(6):2440-5. PubMed ID: 16322477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
    Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-25 is involved in cutaneous T-cell lymphoma progression by establishing a T helper 2-dominant microenvironment.
    Nakajima R; Miyagaki T; Hirakawa M; Oka T; Takahashi N; Suga H; Yoshizaki A; Fujita H; Asano Y; Sugaya M; Sato S
    Br J Dermatol; 2018 Jun; 178(6):1373-1382. PubMed ID: 29238954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.
    Guenova E; Watanabe R; Teague JE; Desimone JA; Jiang Y; Dowlatshahi M; Schlapbach C; Schaekel K; Rook AH; Tawa M; Fisher DC; Kupper TS; Clark RA
    Clin Cancer Res; 2013 Jul; 19(14):3755-63. PubMed ID: 23785046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas.
    Rawat R; Rainey GJ; Thompson CD; Frazier-Jessen MR; Brown RT; Nordan RP
    Blood; 2000 Nov; 96(10):3514-21. PubMed ID: 11071649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
    Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
    J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.